collagen-based medicines

Endo pays $658M in a further bet on collagen-based medicines, buying out longtime biopharma partner
Endpoints
Mon, 10/19/20 - 10:42 am
Endo Pharmaceuticals
M&A
BioSpecifics Technologies
collagen-based medicines